Home > Cashflow Statement > AARTI DRUGS

AARTI DRUGS
Cash Flow from Financing Activities

    Back to Cashflow Statement
COMMUNITY POLL
for AARTI DRUGS
Please provide your vote to see the results

AARTI DRUGS Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Cash Flow from Financing Activities ₹-136 Cr₹17 Cr₹92 Cr₹-81 Cr₹-215 Cr

What is the latest Cash Flow from Financing Activities ratio of AARTI DRUGS ?

The latest Cash Flow from Financing Activities ratio of AARTI DRUGS is ₹-136 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Financing Activities
Mar2024₹-136 Cr
Mar2023₹17 Cr
Mar2022₹92 Cr
Mar2021₹-81 Cr
Mar2020₹-215 Cr

How is Cash Flow from Financing Activities of AARTI DRUGS Trending?

Years Cash Flow from Financing Activities % Change
Mar2024 ₹-136 Cr
Negative
Mar2023 ₹17 Cr
-82.02
Mar2022 ₹92 Cr
Positive
Mar2021 ₹-81 Cr
Negative
Mar2020 ₹-215 Cr -

Compare Cash Flow from Financing Activities of peers of AARTI DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI DRUGS ₹3,858.8 Cr -7.4% -5.3% -15.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,936.0 Cr -5.8% -3.2% 35.1% Stock Analytics
DIVIS LABORATORIES ₹152,157.0 Cr -2.8% -3.6% 44.7% Stock Analytics
CIPLA ₹116,200.0 Cr -3.9% -0.5% 13.9% Stock Analytics
DR REDDYS LABORATORIES ₹111,325.0 Cr -1.2% 7.1% 17.8% Stock Analytics
ZYDUS LIFESCIENCES ₹98,037.4 Cr -2.7% -0.1% 40.9% Stock Analytics


AARTI DRUGS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI DRUGS

-7.4%

-5.3%

-15.6%

SENSEX

-2.1%

-6.4%

7%


You may also like the below Video Courses